Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,863 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 46,863 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.85 | $101.75 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,343 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 04, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 45 | $1.79 | $80.55 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,288 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 03, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.85 | $101.75 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,243 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 02, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.89 | $103.95 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,188 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.90 | $104.50 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,133 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 28, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.96 | $107.80 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,078 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 27, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.98 | $108.90 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,023 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 26, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.07 | $113.85 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,968 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 25, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.24 | $123.20 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,913 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 22, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.29 | $125.95 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,858 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 21, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.28 | $125.40 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,803 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 20, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.14 | $117.70 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,748 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 19, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.12 | $116.60 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,693 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 18, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.03 | $111.65 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,638 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 15, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 23 | $1.82 | $41.86 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,583 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 14, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.84 | $119.60 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,560 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 13, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.83 | $118.95 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,495 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 12, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.76 | $114.40 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,430 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 11, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.72 | $111.80 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,365 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 08, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.68 | $109.20 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,300 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 07, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.68 | $109.20 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,235 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 06, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.65 | $107.25 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,170 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 05, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.68 | $109.20 |
DisclosureSEC source: 0001214659-23-013094 · marketforms-62745.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,105 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 31, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.67 | $108.55 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,040 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 30, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.68 | $109.20 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,975 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 29, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 70 | $1.67 | $116.90 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,910 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 28, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.71 | $111.15 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,840 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 25, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.70 | $110.50 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,775 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 24, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 27 | $1.69 | $45.63 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,710 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 23, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.70 | $110.50 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,683 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 22, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.72 | $111.80 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,618 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 21, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.68 | $109.20 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,553 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 18, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.70 | $110.50 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,488 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 17, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.70 | $110.50 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,423 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 16, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 65 | $1.64 | $106.60 |
DisclosureSEC source: 0001214659-23-012223 · marketforms-62531.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,358 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 21:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $1.97 | $1,970.00 |
DisclosureSEC source: 0001209191-23-021266 · doc4.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,293 F1 · shares: Restricted stock award will vest 100% on March 24, 2024. Read SEC document |
| December 21, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 88 | $2.22 | $195.36 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,293 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 20, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 121 | $2.31 | $279.51 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,205 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 19, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 70 | $2.21 | $154.70 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,084 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 16, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 40 | $2.22 | $88.80 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,014 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 15, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 20 | $2.24 | $44.80 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,974 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 14, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 40 | $2.21 | $88.40 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,954 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 13, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 40 | $2.18 | $87.20 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,914 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 12, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $2.14 | $66.34 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,874 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 09, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $2.15 | $66.65 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,843 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 08, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $2.19 | $67.89 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,812 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 07, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $2.18 | $67.58 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,781 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 06, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $2.19 | $67.89 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,750 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 05, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $2.19 | $67.89 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,719 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 02, 2022 Filed Dec 23, 2022 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 31 | $2.31 | $71.61 |
DisclosureSEC source: 0001209191-22-062654 · doc4.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,688 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.